Tim Bohen’s Top Trade Idea

You’ll wanna keep an eye on this 65% winner… ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [StocksToTrade Live]( Top Trade Idea From The Trading Desk of Tim Bohen Hey. Tim Bohen here. A bunch of stocks were on the move today and we had lots of gains, long and short, from our Oracle signals… Allarity Therapeutics Inc. (NASDAQ: ALLR) was insane! The red signal hit right after the open and the stock proceeded to crash. By the time it reached its low for the day, the short trade had returned 58.55%. Allarity Therapeutics (NASDAQ: ALLR) Oracle usually knows what’s up but it truly hit the nail on the head with this on this one. Wanna make returns like the ALLR short? [Get access to the Oracle system as well as my daily trading plans](. Our other top winner came from Nuwellis Inc. (NASDAQ: NUWE). This morning, the company announced a new patent allowance related to its renal replacement therapy. We got the Oracle signal when it was trading at $0.16. It went on to reach new day highs until it this afternoon peaked today at $0.2644. Nuwellis Inc. (NASDAQ: NUWE) Now I realize those tiny per share numbers don’t seem like much but that price move created a 65.25% gain, in one day. That’s a big deal. Apply that number to a $500 investment and you’ll see what I mean… Watch NUWE tomorrow for another potential long signal. Don’t miss my[free live training tonight at 9 pm Eastern]( where you can learn all of my best trading strategies and ideas. Tim Bohen Lead Trainer, StocksToTrade   [Click Here to Unsubscribe]( 13809 Research Boulevard, Suite 500, Austin, TX 78750 This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com